Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Genitourin Cancer. 2015 Feb;13(1):1-9. doi: 10.1016/j.clgc.2014.09.001. Epub 2014 Sep 28.

Combining immunotherapy and radiation for prostate cancer.

Author information

1
21st Century Oncology Translational Research Consortium, Scottsdale, AZ. Electronic address: sfinkels@rtsx.com.
2
21st Century Oncology Translational Research Consortium, Fort Myers, FL.
3
Carolina Urologic Research Center, 21st Century Oncology, Myrtle Beach, SC.
4
21st Century Oncology Translational Research Consortium, Scottsdale, AZ.
5
Dendreon Corporation, Seattle, WA.

Abstract

Radiotherapy has conventionally been viewed as immunosuppressive, which has precluded its use in combination with immunotherapy for prostate and other cancers. However, the relationship between ionizing radiation and immune reactivity is now known to be more complex than was previously thought, and data on the use of radiotherapy and immunotherapy are accumulating. Herein, we review this topic in the light of recently available data in the prostate cancer setting. Recent research has shown no significant lymphopenia in patients undergoing radiotherapy for high-risk adenocarcinoma of the prostate. In addition, emerging evidence suggests that radiotherapy can have immunostimulatory effects, and that tumor cell death, coupled with related changes in antigen availability and inflammatory signals, can affect lymphocyte and dendritic cell activation. Initial studies have focused on combinations of tumor irradiation and immunotherapy, such as the autologous cellular immunotherapy sipuleucel-T and the monoclonal antibody ipilimumab, in metastatic castration-resistant prostate cancer. These combinations appear to have clinical promise, and further investigation of the potentially synergistic combination of radiotherapy and immunotherapy is continuing in clinical trials.

KEYWORDS:

Cancer vaccine; Prostatic neoplasm; Radiation effects; Radiotherapy

PMID:
25450032
DOI:
10.1016/j.clgc.2014.09.001
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center